Arrowhead Pharmaceuticals, Inc.
ARWR NASDAQHealthcare ★★★★★Latest Earnings
Date
Aug 4, 2026
ET
EPS Est.
-1.28
EPS Actual
-1.36
Revenue Est.
$44.2M
Revenue Actual
$75.3M
Next Earnings Report Date unconfirmed
Date
Nov 24, 2026 · Tue
Time
Time TBD
Fiscal Period
--
EPS Est.
-1.53
Revenue Est.
$71.8M
Company Overview
Arrowhead Pharmaceuticals, Inc. (ticker ARWR) is listed on NASDAQ with a market cap of about $12.27B. Its next earnings report is expected on Nov 24, 2026 (ET), Time TBD (date pending company confirmation), with consensus EPS of -1.53. In the last 15 reported quarters, EPS beat consensus estimates 3 times.
Actual EPS TrendRecently15Term · Feb 6, 2023 → Aug 4, 2026
Feb 6, 2023Range: -1.39 ~ 2.75Aug 4, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 4, 2026 | -- | -1.28 | -1.36 | $44.2M | $75.3M |
| May 7, 2026 | -- | -1.09 | -0.93 | $73.8M | $73.7M |
| Feb 5, 2026 | -- | 0.60 | Below forecast↓0.22 | $213.9M | $264M |
| Nov 25, 2025 | -- | -0.11 | Below forecast↓-0.18 | $175.3M | $256.5M |
| Aug 7, 2025 | -- | -0.94 | Below forecast↓-1.26 | $154.1M | $27.8M |
| May 12, 2025 | -- | -0.06 | Above forecast↑2.75 | $116.3M | $542.7M |
| Feb 10, 2025 | -- | -0.42 | Below forecast↓-1.39 | $19.1M | $2.5M |
| Nov 26, 2024 | -- | -1.05 | Below forecast↓-1.38 | $55.1M | $3.6M |
| Aug 8, 2024 | -- | -0.58 | Below forecast↓-1.38 | $69.7M | -- |
| May 9, 2024 | -- | -0.06 | Below forecast↓-1.02 | $63.9M | -- |
| Feb 6, 2024 | -- | -0.78 | Below forecast↓-1.24 | $29.5M | $3.6M |
| Nov 29, 2023 | -- | -0.70 | Below forecast↓-1.03 | $50.7M | $16.1M |
| Aug 7, 2023 | -- | -0.58 | Below forecast↓-0.96 | $59.8M | $15.8M |
| May 2, 2023 | -- | -0.64 | Above forecast↑0.45 | $45.5M | $146.3M |
| Feb 6, 2023 | -- | 1.14 | Below forecast↓-0.39 | $162.5M | $62.5M |
Original Filings (SEC)
8-K2026-08-04 ↗
10-Q2026-08-04 ↗
8-K2026-06-16 ↗
10-Q2026-05-07 ↗
8-K2026-05-07 ↗
8-K2026-03-20 ↗
10-Q2026-02-05 ↗
8-K2026-02-05 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
